Screener Summaries Updates Institutions Sign In More Updates › Earnings › BIIB Earnings · Oct 30, 2025
Biogen Inc. has released its financial results and operating performance for the third quarter ended September 30, 2025 BIIB Biogen Inc.
Biogen Inc. has released its financial results and operating performance for the third quarter ended September 30, 2025. This announcement is a key event for investors as it provides the latest data regarding the company's quarterly revenue, profitability, and overall financial health.
More from Biogen Inc. Biogen reports Q3 revenue of $2.8B, up 11%, and raises full-year Non-GAAP EPS guidance to $12.20-$13.00 Oct 28, 2026 Biogen Inc. reported second quarter 2026 financial results with total revenue of $2.7 billion, a 3% year-over-year… Jul 29, 2026 Biogen Inc. expects to incur approximately $164 million in pre-tax acquired in-process research and development… Jul 1, 2026 Biogen Inc. filed this amendment to its May 14, 2026, Form 8-K to clarify that the acquisition of Apellis… Jun 10, 2026 Biogen has completed its acquisition of Apellis Pharmaceuticals for approximately $5.3 billion, funded in part by a… May 14, 2026 All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.
